Atlas Trials

Dose Escalation Study With Expansion to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of CCT3833

Clinical trial NCT02437227 · COMPLETED

Trial details

NCT number
NCT02437227
Sponsor
Royal Marsden NHS Foundation Trust
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
MelanomaCancer
Start date
2015-04-15
Primary completion
2017-12-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.